EUVIMEDEUVIMED entdecken
Crossref

The RNA-stability-independent role of the RNA m6A reader YTHDF2 in promoting protein translation to confer tumor chemotherapy resistance

Tao Liu, Dan Yang, Qinglv Wei, Yuan Wang, Lei Tian, Xiaoyi Liu, Yu Yang, Qingya Luo, Jie Xu, Yujiao Liu, Chenyue Yang, Xinzhao Zuo und 9 weitere

Molecular Cell · 2025

DOI: 10.1016/j.molcel.2025.05.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Cell, 2025. Verfasst von Tao Liu und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, China; Department of Obstet…. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Ovarian Neoplasms, RNA-Binding Proteins, Adenosine. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chongqing Municipal Health Commission, Natural Science Foundation Project of Chongqing.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N6-methyladenosine (m6A) modification plays pivotal roles in myriad biological processes. The YTH domain family protein YTHDF2, recognized as an m6A "reader" protein, is primarily associated with the canonical function of facilitating RNA degradation. Nevertheless, the intricate non-decay regulatory mechanism exerted by YTHDF2 remains enigmatic. Here, using ovarian cancer as a model, we demonstrate that YTHDF2 forms a tangible interaction with the eukaryotic translation initiation factor eIF3F and the RNA helicase DDX1, thereby enhancing protein synthesis in tumor cells. Instead of promoting RNA degradation, YTHDF2 facilitates the translation of m6A-modified mRNAs encoding microtubule-associated proteins, which drives cancer progression and reduces the chemosensitivity of cancer cells to paclitaxel, a commonly used chemotherapy drug. Notably, through virtual screening, we identified a YTHDF2-specific small-molecule inhibitor. Therapeutic targeting of YTHDF2 with this inhibitor effectively suppresses protein translation in tumor cells and reverses paclitaxel resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmOvarian NeoplasmsRNA-Binding ProteinsAdenosineProtein BiosynthesisRNA StabilityHumansPaclitaxelFemaleCell Line, TumorDEAD-box RNA HelicasesGene Expression Regulation, NeoplasticRNA, MessengerAnimalsEukaryotic Initiation Factor-3Mice

Stichwörter der Autor:innen

YTHDF2m(6)Atranslational regulationtumor resistance

Substanzen

YTHDF2 protein, humanPaclitaxelRNA-Binding ProteinsAdenosineN-methyladenosineDEAD-box RNA HelicasesRNA, MessengerEukaryotic Initiation Factor-3

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, China; Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Chongqing Medica…
  • Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing 401120, China.
  • Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of California, Irvine, Irvine, CA 92697, USA; Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA…
  • Department of Pathology, Southwest Hospital, Army Medical University, Chongqing 401120, China.
  • Department of Obstetrics and Gynecology, Daping Hospital, Army Medical University, Chongqing 400042, China.
  • Department of Biochemistry, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC), Beijing 100021, China.

Förderung

  • National Natural Science Foundation of China
  • Chongqing Municipal Health Commission
  • Natural Science Foundation Project of Chongqing
  • Chongqing Medical University
  • Natural Science Foundation of Chongqing Municipality

Zitieren

APA

Liu, T., Yang, D., Wei, Q., Wang, Y., Tian, L., Liu, X., Yang, Y., Luo, Q., Xu, J., Liu, Y., Yang, C., Zuo, X., Luo, F., Luo, X., Zhao, H., Li, L., Xu, J., Yu, J., Ma, S., …, & Yi, P. (2025). The RNA-stability-independent role of the RNA m6A reader YTHDF2 in promoting protein translation to confer tumor chemotherapy resistance. Molecular Cell. https://doi.org/10.1016/j.molcel.2025.05.015

Vancouver

Liu T, Yang D, Wei Q, Wang Y, Tian L, Liu X, et al. The RNA-stability-independent role of the RNA m6A reader YTHDF2 in promoting protein translation to confer tumor chemotherapy resistance. Molecular Cell. 2025. doi:10.1016/j.molcel.2025.05.015

BibTeX
@article{Liu2025,
  author = {Liu, Tao and Yang, Dan and Wei, Qinglv and Wang, Yuan and Tian, Lei and Liu, Xiaoyi and Yang, Yu and Luo, Qingya and Xu, Jie and Liu, Yujiao and Yang, Chenyue and Zuo, Xinzhao and Luo, Fatao and Luo, Xin and Zhao, Hongyan and Li, Li and Xu, Jing and Yu, Jia and Ma, Shoubao and Yu, Jianhua and Yi, Ping},
  title = {The RNA-stability-independent role of the RNA m6A reader YTHDF2 in promoting protein translation to confer tumor chemotherapy resistance},
  journal = {Molecular Cell},
  year = {2025},
  doi = {10.1016/j.molcel.2025.05.015}
}
Kostenlos starten →